Senescent Cells May Survive by Shedding Damaged Parts

Senescent cells are often described as damaged cells that stop dividing but refuse to die. A new study suggests that at least some of them stay alive through a surprisingly physical survival mechanism: they tear off membrane-bound pieces of themselves and leave those fragments attached to nearby cells.

The fragments can carry damaged mitochondria and other intracellular material. By shedding that burden, the senescent cells may protect themselves from further stress. The discarded material does not simply disappear, however. It can rupture and release proteins and molecular danger signals into the surrounding tissue.

The study, published August 28 in Developmental Cell, names these structures senescent-cell adhesion fragments, or SCAFs. The work identifies a previously underappreciated way in which senescent cells may remain viable while depositing potentially harmful debris around neighboring cells.

The finding is mechanistically important, but it is not a human treatment result. The experiments involved cultured human and mouse cells and a specific induced senescence model in mouse liver tissue. The researchers did not show that blocking SCAFs improves health or lifespan in people.

Evidence at a glance

Study type: Peer-reviewed mechanistic research using cultured human and mouse cells, live-cell imaging, electron microscopy, proteomics and an induced mouse-liver senescence model.
Evidence level: Early Research.
Main finding: Senescent cells formed large membrane-bound fragments through cell-to-cell adhesion. These SCAFs contained damaged mitochondria and other cellular material. Reducing fragment formation caused damaged mitochondria to accumulate and increased senescent-cell death.
Main caution: The study did not test a drug, a clinical intervention or normal human aging. The consequences of SCAFs in living human tissues remain unknown.

What the researchers found

The team, led by researchers at the Institute of Genetics and Molecular and Cellular Biology in France and collaborators in France and Germany, examined multiple forms of cellular senescence. Senescence is a stress response in which a cell enters a durable state of growth arrest. It no longer divides, yet it can remain metabolically active and influence surrounding tissue.

Using live imaging, the researchers saw senescent cells attach to neighboring cells. When the cells moved apart, the point of contact stretched into a tether. That tether eventually tore, leaving a large membrane-bound fragment behind. The parent cell and the fragment both appeared to reseal after separation.

These structures were not limited to one cell line or one way of producing senescence. The final paper reports SCAFs across multiple senescent states in human and mouse cells, as well as in mouse tissue. In the animal experiment, the researchers identified SCAF-like fragments in hepatocytes made senescent by an engineered oncogene in the liver.

The fragments were much larger and more structurally complex than the small extracellular vesicles that cells routinely release. Electron microscopy showed membrane-bound bodies containing cytoplasm and recognizable organelles. The paper reports damaged mitochondria among their contents, while the accompanying work also identified structures such as endoplasmic reticulum, lipid droplets, vesicles and autophagic material.

The fragments did not contain a nucleus or detectable nuclear material. That detail supports the idea that they are pieces shed from a living senescent cell rather than complete cells or ordinary cell division products.

Why damaged mitochondria matter

Mitochondria generate much of a cell’s usable energy, but they also help regulate metabolism, stress responses, inflammation and programmed cell death. Damaged mitochondria can produce abnormal signals, leak molecular material and intensify cellular stress. Cells normally rely on quality-control systems, including mitophagy, to remove mitochondria that are no longer functioning properly.

Mitophagy is a selective form of cellular recycling. A damaged mitochondrion is enclosed and delivered to the cell’s degradation machinery. Senescent cells often have disrupted mitochondrial function and impaired quality control, which can leave them with an unusually large burden of damaged organelles.

The new work suggests that SCAF formation may provide an additional disposal route. When the researchers disrupted adherens junctions, the cell-to-cell structures that help anchor neighboring cells together, SCAF formation fell. Damaged mitochondria then accumulated inside the senescent cells, and more of those cells died.

That experiment links fragment shedding to senescent-cell survival. It does not prove that every senescent cell depends on the process or that the same mechanism operates in every tissue. It does show that, in the studied models, SCAFs were more than passive debris. They helped cells manage intracellular damage.

The debris may affect nearby tissue

Survival for the senescent cell could create a cost for its surroundings. The researchers found that SCAFs eventually ruptured and released a complex collection of proteins. That material included damage-associated molecular patterns, or DAMPs, which are molecules that can alert the immune system when they appear outside their normal cellular location.

Proteomic analysis also detected proteins linked to neurodegenerative disease. Immunostaining identified amyloid-like material inside senescent cells that could be externalized through fragmentation. These observations do not show that SCAFs cause Alzheimer’s disease or another neurodegenerative disorder. They identify a possible route by which abnormal intracellular material could be deposited outside a damaged cell.

In laboratory experiments, exposure to SCAF material activated gene programs associated with wound healing and cancer-related behavior. The fragments promoted migration and invasion in the tested cell systems. Those results suggest that the debris can carry biological activity, but cultured-cell behavior is not the same as tumor growth or tissue degeneration in a living person.

Why this matters for aging

Cellular senescence is not inherently harmful. It helps prevent damaged cells from continuing to divide, participates in wound repair and contributes to normal development. Problems can arise when senescent cells accumulate and remain in tissue for long periods.

Much of the field has focused on the senescence-associated secretory phenotype, or SASP. This is the mixture of inflammatory molecules, growth factors and other signals released by senescent cells. SCAFs appear to represent a different route of communication and disposal. Instead of secreting individual molecules or small packages, a cell can physically tear away a large section containing organelles and cytoplasm.

This distinction matters because it may help explain two persistent features of senescence: why damaged cells can remain alive despite internal stress, and how they may alter the local tissue environment beyond conventional secretion.

The mouse-tissue finding gives the mechanism more biological relevance than a culture-only observation. Even so, the in vivo evidence came from an experimentally induced liver model. The study did not measure SCAFs across naturally aging animals, establish how common they are in older human tissues or show whether their abundance tracks with disease.

Could this matter for senolytics?

Senolytics are drugs or experimental compounds intended to selectively eliminate senescent cells. The basic strategy is to exploit survival pathways that senescent cells rely on more heavily than healthy cells do.

SCAF formation now looks like a potential survival dependency in the models studied. If a senescent cell needs adhesion-dependent fragmentation to discard damaged mitochondria, interrupting that process could make the cell more vulnerable to its own accumulated stress.

That possibility is a research hypothesis, not a proposed treatment. Adherens junctions are essential to the structure and function of healthy tissues. Broadly disrupting them could harm normal cells, weaken tissue barriers or create effects unrelated to senescence. Any therapeutic approach would need to target the process selectively and show that benefits outweigh those risks.

The study did not test a senolytic drug, compare treatment strategies or demonstrate improved health after SCAF inhibition. It identifies a mechanism that future researchers can examine for selectivity, druggability and relevance in living organisms.

What we still do not know

How frequently SCAFs form during ordinary aging in humans.
Which senescent cell types depend most strongly on fragment shedding.
Whether immune cells clear the fragments efficiently in healthy tissue.
Whether SCAF debris directly drives chronic inflammation, cancer progression or neurodegeneration in living animals.
Whether reducing SCAF formation can safely remove harmful senescent cells without damaging normal tissue architecture.
Whether the process changes with age, disease, treatment or the location of the senescent cell.

Answering those questions will require natural-aging models, studies across multiple tissues, direct measurements in human samples and interventions designed to separate SCAF formation from the many other functions of cell adhesion.

The Lifespan Brief take

This study adds a striking physical dimension to senescence biology. Some senescent cells appear able to survive by tearing off fragments that carry damaged mitochondria and other material. The process may relieve internal stress while shifting part of that burden into the surrounding tissue.

The strongest conclusion is narrow but important: adhesion-dependent fragmentation supported senescent-cell viability in the experimental models. The larger implications for inflammation, cancer, neurodegeneration and senolytic therapy remain plausible directions for research rather than demonstrated clinical outcomes.

For aging science, the work is valuable because it reveals a mechanism that was easy to miss when attention centered mainly on secreted molecules. It offers a new way to investigate both the persistence of senescent cells and the debris they leave behind.

Senescent Cells May Survive by Shedding Their Damaged Parts